KPV Free Base vs KPV Acetate: What Is the Difference for Research Buyers?

Oct 01, 2026 Leave a message

KPV (Lys-Pro-Val) is supplied in more than one molecular form. In supplier documentation, "KPV free base" is sometimes used informally for KPV supplied without a specified acetate or TFA counter-ion. Chemically, however, the C-terminal free-acid form (H-Lys-Pro-Val-OH) and the counter-ion status are separate attributes. Both "free base" and "acetate" products may contain the same KPV peptide sequence, but they can differ in terminal form, counter-ion content, water content and peptide assay. These differences affect the amount of active peptide per gram of supplied powder. Research buyers should verify both the terminal form and counter-ion content on the batch documentation, and should not substitute one supplied form for another on a weight-for-weight basis without adjusting for the active-peptide fraction.

 

Quick Answer

KPV products may share the same Lys-Pro-Val peptide sequence while differing in terminal form, counter-ion content, water content and peptide assay. These differences affect the amount of active peptide per gram of supplied powder.

HPLC purity and peptide content (assay) are different: "98% HPLC" does not mean 98 mg active peptide per 100 mg powder.

Do not substitute supplied forms by weight; recalculate using the supplier's confirmed peptide-content basis.

 

 

 

 

What Is KPV Free Acid?

 

The C-terminal free-acid form of KPV is H-Lys-Pro-Val-OH. In this terminal form, the C-terminus carries a carboxylic acid group rather than an amide. Its theoretical identity parameters are:

Sequence: Lys-Pro-Val (H-Lys-Pro-Val-OH)

CAS: 67727-97-3 (for the specified free-acid form; verify against the exact molecular form and batch documentation)

Molecular formula: C₁₆H₃₀N₄O₄

Molecular weight: 342.43 g/mol (free-acid form)

Appearance: White or off-white powder

The term "free base" in supplier catalogs sometimes refers to material supplied without a specified acetate or TFA counter-ion, but this is not the same as the C-terminal free-acid terminal form. Even a product labeled "free base" or "free acid" may contain residual water, trace counter-ions from purification, or residual solvents. The theoretical molecular weight is a reference value; the actual active-peptide content per gram must be confirmed from the batch-specific certificate of analysis (COA).

 

 

What Is KPV Acetate?

 

KPV acetate refers to KPV supplied with acetate as a counter-ion. The amount of acetate associated with the peptide is product- and batch-dependent and should not be assumed from the product name alone. For peptides with multiple ionizable sites, the actual counter-ion stoichiometry can vary, and a product labeled "acetate" does not automatically correspond to a fixed 1:1 salt.

 

Counter-ion content, water and other non-peptide components affect the amount of active peptide per gram of supplied powder. For quantitative work, buyers should use the batch-specific peptide assay and counter-ion data rather than a theoretical salt calculation. The supplier should report:

  • Acetate content - measured, for example, by ion chromatography
  • Water content - measured by Karl Fischer titration
  • Peptide content (assay) - the quantitative active-peptide basis used for dosing
  • Detection and calculation basis - whether assay is determined by amino-acid analysis, UV absorbance, or another validated method

CAS numbers are also not consistent across suppliers. Some list the same CAS (67727-97-3) for both free-acid and acetate forms; others may use different identifiers. Verify the exact molecular form, counter-ion content and analytical identity from the batch COA rather than relying on the CAS number alone.

 

 

Is KPV Amide the Same Product?

 

No. KPV can be supplied with different terminal modifications, and these are not interchangeable:

  • H-Lys-Pro-Val-OH - C-terminal free acid (free acid)
  • H-Lys-Pro-Val-NH₂ - C-terminal amide
  • Acetylated KPV - N-terminal acetylation
  • KPV with acetate counter-ion - counter-ion status should be documented separately from terminal modification

 

The terminal form affects molecular weight, charge, solubility and potentially biological behavior. A product labeled simply "KPV" should always be accompanied by documentation specifying the exact terminal form and counter-ion status. Buyers should not assume that "KPV" from one supplier is molecularly identical to "KPV" from another.

 

Why HPLC Purity Is Not Peptide Content

 

HPLC area purity and peptide content (assay) describe different attributes and should not be treated as interchangeable values.

HPLC purity reflects the relative chromatographic purity of the peptide peak - the area of the target peptide peak relative to all peptide-related peaks detected at the peptide-absorbing wavelength. It does not account for water, counter-ions, or residual salts, which do not appear as peptide impurity peaks.

Peptide content (assay) is the amount of active peptide present in the supplied material, expressed as a percentage of total mass. It accounts for counter-ions, water and other non-peptide mass.

The actual peptide amount in a weighed sample is calculated as:

Actual peptide amount = Powder weight × Peptide-content fraction

 

For example (illustrative only - use the assay from the confirmed COA): if a supplied KPV powder has a peptide content of 80%, then 10 mg of powder contains approximately 8 mg of active KPV peptide. A product with high HPLC purity can still have a materially lower peptide-content value because water, counter-ions and other non-peptide mass are not represented by HPLC area purity. Buyers should dose based on the confirmed peptide-content basis, not on the HPLC purity number alone.

 

 

KPV PURITY

 

 

How to Use Analytical Data for Quantitative Dosing

 

For research procurement, the most reliable quantitative basis is the batch-specific peptide assay, not a theoretical calculation derived from counter-ion molecular weight. Each analytical test addresses a different attribute:

LC-MS - confirms the principal molecular mass and peptide identity, including terminal form (free acid vs amide).

HPLC - assesses chromatographic purity (target peptide vs peptide-related impurities).

Counter-ion assay - measures acetate or TFA content, typically by ion chromatography.

Karl Fischer titration - determines residual water content.

Peptide content (assay) - provides the quantitative active-peptide basis used for dosing.

Counter-ion content and water both contribute to the total mass of supplied powder without adding active peptide. However, for peptides with multiple ionizable sites, the exact counter-ion stoichiometry can vary between products and batches. Estimating active content from a theoretical counter-ion molecular weight therefore introduces avoidable uncertainty.

For quantitative dosing, use the batch-specific peptide-content or assay basis reported by the supplier rather than estimating active content from a theoretical counter-ion molecular weight. If the supplier does not report a peptide assay, request one before using the material for quantitative work.

 

Which Analytical Tests Should Be Used?

 

Test Primary Purpose
HPLC Assess chromatographic purity (target peptide vs peptide-related impurities)
LC-MS Confirm principal molecular mass and peptide identity
Amino-acid analysis Support composition or peptide-content assessment
Karl Fischer Determine residual water
Ion chromatography Measure acetate or TFA content
Residual-solvent testing Evaluate synthesis/purification solvent residues

 

A complete quality package should include the batch COA with HPLC purity, peptide content (assay), water content, counter-ion content, and supporting chromatogram and mass-spectrum data. LC-MS is particularly important for confirming that the supplied material matches the claimed terminal form (free acid vs amide vs acetylated) and sequence.

 

How Should Buyers Choose?

 

The choice between KPV supplied forms depends on the research context:

Research protocol and reference standard - Match the form and assay basis specified in the protocol or published study; document which form was used and how the dose was calculated.

Required terminal form and counter-ion - Some applications require a specific terminal form (free acid vs amide) or counter-ion status; ensure LC-MS confirms identity regardless of counter-ion.

Assay basis - Always dose based on the confirmed peptide-content fraction, not on labeled powder weight or HPLC purity.

Storage and batch consistency - Follow the supplier's storage recommendations; request batch-specific COA for every shipment and verify assay basis and counter-ion consistency.

 

FAQ

 

Is KPV acetate the same as KPV?

KPV acetate contains the same Lys-Pro-Val sequence but is supplied with an acetate counter-ion, changing the active-peptide fraction per gram. It is not weight-for-weight equivalent to material supplied without a specified counter-ion.

 

Does acetate change the amino-acid sequence?

No. The acetate counter-ion does not alter the Lys-Pro-Val sequence; it is associated with the peptide as a salt and contributes to non-peptide mass.

 

Can supplied forms be substituted directly?

No. Different supplied forms contain different amounts of non-peptide mass (counter-ion and potentially water), so the same powder weight provides different amounts of active peptide. Recalculate using the supplier's confirmed peptide-content (assay) basis.

 

Why is peptide content lower than HPLC purity?

HPLC purity measures the target peptide relative to peptide-related impurities only; it does not account for water, counter-ions or residual salts. Peptide content (assay) measures actual peptide as a percentage of total mass, so it is typically lower.

 

Which molecular weight should be used?

Use the measured LC-MS mass for identity confirmation. For dosing, use the batch-specific peptide-content or assay basis reported by the supplier (which accounts for counter-ions and water). Do not estimate active content from a theoretical counter-ion molecular weight.

 

Looking for KPV peptide powder for laboratory research? HDM Biotech provides batch-specific COA, HPLC and LC-MS documentation, counter-ion and water analysis, sample support and bulk supply options according to the confirmed product specification.

Contact:
Whatsapp & Mobile: +86 19991242181

Email:sales@hdmbio.com

 

References

  1. PubChem. KPV - Lys-Pro-Val. CID 125672. National Library of Medicine. Accessed 2026.
  2. ICH Q6A. Specifications: Test Procedures and Acceptance Criteria for New Drug Substances and New Drug Products. International Council for Harmonisation.
  3. ICH Q2(R2). Validation of Analytical Procedures. International Council for Harmonisation.
  4. European Pharmacopoeia. Ion chromatography (2.2.29); Water - semi-micro determination (2.5.12). Council of Europe.

Send Inquiry

whatsapp

Phone

E-mail

Inquiry